Application for quotation of +securities
The document “Application for quotation of +securities” was lodged with ASX on 6th January, 2022. Please click to review the full announcement at ASX.
The document “Application for quotation of +securities” was lodged with ASX on 6th January, 2022. Please click to review the full announcement at ASX.
The document “Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001” was lodged with ASX on 6th January, 2022. Please click to review the
Tim Boreham revisits Imagion Biosystems’ potential in this 5-1/2 page article profiling the company and discussing its recent milestones. Read the article here.
The document “Notification of Issue, Conversion of Payment up of Unquoted Equity +Securities” was lodged with ASX on 16 December, 2021. Please click to review
The document “Remuneration Update and Employee Equity Incentives” was lodged with ASX on 16 December 2021. Please click to review the full announcement at ASX.
We are pleased to provide our investors with our December 2021 Investor Newsletter. In this edition, our Executive Director and CEO Bob Proulx gives an
Highlighting our dedicated employees who bring both their experience and passions to Imagion Biosystems: We sat down with Carmen Soikowski, who joined us as our
Imagion Biosystems is pleased to advise that it has now received the full $4.8 million from the exercise of all 96,706,395 listed options (IBXO) which
The following Appendix 2A was announced via ASX on 1 Dec 2021. Please click to review full announcement.
The following cleansing notice was lodged with ASX on December 1, 2021: Imagion Biosystems Limited (ASX: IBX) (the Company) gives notice that, between 26 November
Stay informed about our latest news and developments.
© Imagion Biosystems, Ltd. All Rights Reserved | Privacy Policy | Terms & Conditions | Careers | Corporate Governance